Skip to content

Children's Vaccines Health Center

Font Size

Seizure Risk Rises With MMRV Vaccine

Febrile Seizures Nearly Double With Measles-Mumps-Rubella-Chickenpox Vaccine, but Risk Still Slight, Study Says
By
WebMD Health News
Reviewed by Laura J. Martin, MD

June 28, 2010 -- The risk of fever-related seizures in infants nearly doubles with the four-in-one measles-mumps-rubella-chickenpox vaccine (MMRV) compared to when the measles-mumps-rubella (MMR) vaccine and chickenpox vaccine are given separately, according to a new study.

Even so, the risk of febrile seizures -- convulsions brought on by fever -- is low with either approach, says researcher Nicola P. Klein, MD, PhD, a research scientist at the Kaiser Permanente Northern California Division of Research and co-director of the Kaiser Permanente Vaccine Study Center, Oakland.

"Overall, the risk for febrile seizures from all measles-containing vaccines is low, less than 1 febrile seizure per 1,000 doses," Klein says. "However, MMRV is associated with a doubling of the risk of febrile seizures among 1-2-year-olds when compared with children who received separate, same-day administration of MMR and V."

Put another way: ''For a 1- to 2-year-old child who receives MMRV instead of MMR plus V, there will be one additional seizure for every 2,300 doses," Klein says.

The study, published online in the journal Pediatrics, confirms what experts tracking the vaccines have been reporting and adds to preliminary findings by the same group of researchers.

4-in-1 Vaccine: Back Story

The four-in-one vaccine, called ProQuad, was licensed by the FDA in 2005 and later recommended by the CDC's Advisory Committee on Immunization Practices (ACIP) as a way to cut down on the number of shots children needed. The ACIP originally said the four-in-one was preferred over the separate MMR and chickenpox shots.

But Klein and others involved in the CDC-sponsored vaccine safety surveillance known as the Vaccine Safety Datalink reported to the CDC in 2008 that the seizure rate among infants given the four-in-one was about twofold higher than those given the vaccines in two injections.

After that report, the recommendation changed, Klein says, from a preference for the four-in-one to no preference. Currently, the ACIP advises health care providers to discuss the benefits and risks of the four-in-one and to use the MMR and chickenpox vaccines separately for the first dose unless the parent or caregiver expresses a preference for the four-in-one.

Much of the time, the question was a moot point, Klein says, as manufacturing issues (not related to safety, according to the CDC) limited supplies of the four-in-one vaccine.

But ProQuad has recently become available again, says Pamela Eisele, a spokeswoman for Merck, which makes the vaccine.

Vaccines and Seizures Data

In the newly published report, Klein and her team looked at reports of seizures and fevers among more than 376,000 infants given the vaccines in two injections and more than 83,000 given the four-in-one.

Seizures and fever clustered around 7 to 10 days after all measles vaccines, but the risk during that time was higher for the four-in-one than for the two injections.

"There is a doubling of risk with MMRV, but it's [still] slight," she tells WebMD. "There is a low risk overall."

Today on WebMD

Baby getting vaccinated
Is there a link? Get the facts.
syringes and graph illustration
Get a customized vaccine schedule.
 
baby getting a vaccine
Know the benefits and the risk
nurse holding syringe in front of girl
Should your child have it?
 

What To Know About The HPV Vaccine
Article
24 Kid Illnesses Parents Should Know
Slideshow
 
Nausea and Vomiting Remedies Slideshow
Article
Managing Immunization Schedules For Kids
Video
 

Doctor administering vaccine to toddler
Video
gloved hand holding syringe
Article
 
infant receiving injection
Tool
pills
Quiz
 

WebMD Special Sections